Yale New Haven Hospital

Yale New Haven Hospital was paid $1.08B by Medicaid between Jan 2018 and Dec 2024, across 1431 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 11% of everything it billed.

33Billing provider infoYALE NEW HAVEN HOSPITAL
NEW HAVEN, CT 06504

33aNPI1578778726assigned 05/11/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$1.08B

24GClaims23,557,851

24DCodes billed1431

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Connecticut

Rank by total paid#1 of 18

Median peer was paid$15.60M

This provider vs. median69×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WRINN, JACQUELINE controls 12+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,187,533	$143.82M
2019	3,472,216	$160.58M
2020	2,665,329	$126.82M
2021	3,445,785	$155.79M
2022	3,643,212	$165.66M
2023	3,762,455	$168.42M
2024incomplete	3,381,321	$159.47M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	11%	1,248,173	948,888	$115.81M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	10%	158,886	130,232	$112.66M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.8%	242,485	202,899	$95.16M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.0%	231,095	202,783	$53.94M
J2350	Injection, ocrelizumab, 1 mg	3.8%	2,277	1,903	$41.48M
J9271	Injection, pembrolizumab, 1 mg	2.9%	6,184	4,226	$30.85M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.7%	138,750	111,516	$18.58M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.6%	84,180	47,252	$16.87M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	1.6%	15,602	5,346	$16.81M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.4%	3,124	2,942	$15.57M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.4%	230,246	187,597	$15.16M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.4%	7,958	5,726	$14.80M

1419 more codes

95004	Percutaneous tests with allergenic extracts, immediate type reaction	1.2%	4,951	$13.21M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.1%	178,678	$12.05M
J9299	Injection, nivolumab, 1 mg	1.1%	3,908	$11.48M
J2357	Injection, omalizumab, 5 mg	<1%	8,650	$10.58M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	31,253	$8.57M
J9312	Injection, rituximab, 10 mg	<1%	2,754	$8.47M
J2323	Injection, natalizumab, 1 mg	<1%	2,040	$8.13M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	60,298	$7.70M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	2,727	$7.69M
J2505	Injection, pegfilgrastim, 6 mg	<1%	3,437	$7.61M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	51,168	$7.17M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	16,002	$7.06M
S9480	Intensive outpatient psychiatric services, per diem	<1%	62,104	$6.88M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	8,065	$6.69M
71046	Radiologic examination, chest; 2 views	<1%	131,644	$6.57M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	46,446	$6.30M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	8,168	$6.07M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	7,603	$6.00M
77386		<1%	23,963	$5.89M
J0490	Injection, belimumab, 10 mg	<1%	4,354	$5.70M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	41,549	$5.53M
47562		<1%	1,303	$5.50M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	12,536	$5.26M
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	7,413	$5.10M
59025	Fetal non-stress test	<1%	32,174	$5.09M
96361	Intravenous infusion, hydration; each additional hour	<1%	98,749	$4.97M
44970		<1%	986	$4.61M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	22,273	$4.51M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	10,671	$4.47M
J2353	Injection, octreotide, depot form for intramuscular injection, 1 mg	<1%	1,472	$4.43M
96375	Therapeutic injection; each additional sequential IV push	<1%	114,091	$4.40M
J9035	Injection, bevacizumab, 10 mg	<1%	2,503	$4.37M
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	1,016	$4.29M
92587		<1%	17,211	$4.15M
J9022	Injection, atezolizumab, 10 mg	<1%	1,335	$4.01M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	191,595	$3.99M
J0897	Injection, denosumab, 1 mg	<1%	5,714	$3.99M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	19,116	$3.79M
78815	Positron emission tomography (PET) for limited area imaging	<1%	5,614	$3.78M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	857	$3.69M
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	2,690	$3.57M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	34,076	$3.55M
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	1,393	$3.15M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	2,644	$2.96M
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	2,708	$2.94M
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	857	$2.89M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	5,490	$2.78M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	28,265	$2.72M
58571		<1%	490	$2.69M
J0485	Injection, belatacept, 1 mg	<1%	12,494	$2.69M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	25,257	$2.61M
J9310	Injection, rituximab, 100 mg	<1%	739	$2.59M
38222		<1%	2,059	$2.52M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	23,217	$2.47M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	5,051	$2.46M
58558		<1%	1,338	$2.42M
93308		<1%	17,497	$2.39M
70450	Computed tomography, head or brain; without contrast material	<1%	50,048	$2.35M
36430		<1%	11,282	$2.34M
93976		<1%	24,638	$2.33M
76825		<1%	5,056	$2.33M
J9306	Injection, pertuzumab, 1 mg	<1%	857	$2.32M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	11,376	$2.31M
72125	Computed tomography, cervical spine; without contrast material	<1%	26,609	$2.27M
36561		<1%	1,301	$2.22M
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	8,794	$2.17M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	48,184	$2.14M
J9041	Injection, bortezomib, 0.1 mg	<1%	11,602	$2.07M
J9311	Injection, rituximab 10 mg and hyaluronidase	<1%	763	$2.06M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	3,620	$2.05M
J9173	Injection, durvalumab, 10 mg	<1%	612	$2.04M
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	1,656	$2.04M
76830	Ultrasound, transvaginal	<1%	20,735	$2.00M
41899	Unlisted procedure, dentoalveolar structures	<1%	5,161	$1.95M
G0379	Direct admission of patient for hospital observation care	<1%	774	$1.93M
42830		<1%	707	$1.92M
86900		<1%	79,489	$1.91M
95782		<1%	2,044	$1.90M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	2,381	$1.89M
72197		<1%	5,516	$1.88M
96415		<1%	27,631	$1.84M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	30,783	$1.76M
77412		<1%	15,073	$1.76M
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	2,106	$1.76M
93458		<1%	1,159	$1.66M
97162		<1%	31,477	$1.63M
72156		<1%	3,695	$1.60M
58661		<1%	394	$1.59M
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	478	$1.56M
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	2,079	$1.55M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	79,927	$1.55M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	2,501	$1.55M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	77,155	$1.54M
76770		<1%	18,393	$1.51M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	11,371	$1.49M
64721		<1%	1,246	$1.47M
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	66,446	$1.47M
27447		<1%	175	$1.45M
70498		<1%	8,595	$1.42M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	2,391	$1.41M
74183		<1%	8,601	$1.40M
82947		<1%	536,628	$1.36M
96416		<1%	6,975	$1.34M
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	6,337	$1.34M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	111,242	$1.34M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	4,916	$1.32M
J9264	Injection, paclitaxel protein-bound particles, 1 mg	<1%	2,119	$1.32M
71275	Computed tomographic angiography, chest, with contrast material	<1%	12,292	$1.31M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	10,582	$1.29M
64493		<1%	1,660	$1.27M
94060		<1%	6,418	$1.25M
72141		<1%	5,625	$1.25M
76801		<1%	11,547	$1.23M
90870		<1%	5,298	$1.23M
78431		<1%	1,890	$1.22M
Q5123	Injection, rituximab-arrx, biosimilar, (riabni), 10 mg	<1%	790	$1.20M
88184		<1%	9,997	$1.19M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	6,066	$1.16M
J2182	Injection, mepolizumab, 1 mg	<1%	780	$1.14M
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	2,809	$1.14M
71045	Radiologic examination, chest; single view	<1%	28,653	$1.12M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	8,480	$1.11M
J0185	Injection, aprepitant, 1 mg	<1%	8,648	$1.09M
52000		<1%	4,185	$1.09M
64615		<1%	7,707	$1.07M
70544		<1%	3,235	$1.07M
43235		<1%	2,390	$1.04M
93971		<1%	16,018	$1.04M
J9316	Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg	<1%	167	$1.03M
90791	Psychiatric diagnostic evaluation	<1%	11,381	$1.02M
77334		<1%	3,934	$1.02M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	<1%	540	$1.01M
64483		<1%	1,478	$1.01M
93970		<1%	8,448	$1.01M
71250		<1%	16,439	$996K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	1,340	$983K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	2,262	$964K
86902		<1%	1,913	$961K
95911		<1%	2,356	$948K
96409		<1%	6,177	$943K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	20,882	$940K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	9,151	$937K
64642		<1%	2,020	$890K
84443	Thyroid stimulating hormone (TSH)	<1%	153,221	$876K
20610		<1%	4,900	$869K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	4,086	$867K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	4,282	$866K
95812		<1%	3,670	$861K
C9399	Unclassified drugs or biologicals	<1%	381	$845K
77295		<1%	1,333	$840K
70491		<1%	4,731	$839K
19083		<1%	849	$823K
96417		<1%	18,679	$817K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	797,602	$815K
70543		<1%	1,814	$809K
20680		<1%	856	$777K
96900		<1%	30,080	$772K
77301		<1%	1,293	$767K
77066	Tomosynthesis, mammo	<1%	6,750	$761K
J9070	Cyclophosphamide, 100 mg	<1%	6,773	$758K
95811		<1%	1,061	$748K
27130		<1%	90	$737K
97161		<1%	11,954	$731K
G2083	Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation	<1%	1,144	$729K
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	<1%	1,199	$728K
97535	Self-care/home management training, each 15 minutes	<1%	21,668	$723K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	71,371	$721K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	20,774	$720K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	31,400	$719K
G0390	Trauma response team associated with hospital critical care service	<1%	1,053	$719K
31575		<1%	5,979	$713K
78451		<1%	1,458	$711K
72100		<1%	22,614	$711K
77336		<1%	10,076	$704K
93454		<1%	669	$701K
76536		<1%	10,111	$676K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	6,687	$674K
J9395	Injection, fulvestrant, 25 mg	<1%	2,892	$666K
10060		<1%	4,359	$662K
52356		<1%	271	$658K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	8,354	$656K
76641		<1%	7,867	$643K
36512		<1%	779	$634K
73564		<1%	23,912	$629K
73030		<1%	26,264	$629K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	5,908	$628K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	14,708	$620K
75561		<1%	2,193	$614K
73610		<1%	26,744	$599K
73221		<1%	3,354	$587K
73630		<1%	29,888	$586K
76642		<1%	10,616	$583K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	43,073	$580K
62323		<1%	1,226	$577K
86780		<1%	55,090	$572K
96411		<1%	10,521	$567K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	62,588	$560K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	39,400	$559K
83718		<1%	86,548	$558K
54161		<1%	370	$549K
76857		<1%	7,253	$548K
0002A		<1%	14,746	$545K
77300		<1%	3,098	$543K
0001A		<1%	15,592	$533K
73560		<1%	19,505	$518K
31653		<1%	310	$502K
20553		<1%	2,621	$493K
81513		<1%	6,855	$489K
93798		<1%	7,486	$488K
95910		<1%	2,286	$487K
C9467	Injection, rituximab and hyaluronidase, 10 mg	<1%	192	$485K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,581	$479K
99213	Doctor's office visit, returning patient (routine)	<1%	9,589	$474K
92611		<1%	3,168	$472K
95909		<1%	2,174	$467K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,615	$465K
83036	Hemoglobin; glycosylated (A1C)	<1%	139,747	$464K
86480		<1%	23,916	$459K
36415	Collection of venous blood by venipuncture	<1%	671,911	$456K
36593		<1%	2,629	$451K
90832	Psychotherapy session, about 30 minutes	<1%	10,706	$450K
92523		<1%	1,973	$447K
50200		<1%	641	$444K
58662		<1%	180	$439K
96367		<1%	10,205	$433K
82247		<1%	377,988	$432K
97166		<1%	6,745	$431K
72158		<1%	3,621	$422K
97116		<1%	13,635	$416K
76819	Fetal biophysical profile; without non-stress testing	<1%	4,173	$414K
49083		<1%	924	$412K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	2,200	$410K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	341	$403K
77065	Tomosynthesis, mammo	<1%	3,754	$394K
73502		<1%	17,737	$390K
43237		<1%	464	$387K
74178		<1%	2,017	$381K
74230		<1%	3,531	$378K
93975		<1%	2,362	$371K
78816		<1%	566	$368K
31231		<1%	2,440	$368K
70496		<1%	9,068	$367K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	3,781	$362K
J2997	Injection, alteplase recombinant, 1 mg	<1%	3,337	$361K
78306		<1%	1,848	$361K
95951		<1%	1,342	$355K
78492		<1%	676	$354K
82040		<1%	365,131	$354K
82607		<1%	59,032	$350K
43249		<1%	325	$348K
92579		<1%	9,590	$346K
64450		<1%	2,259	$346K
81455		<1%	648	$343K
93351		<1%	1,178	$341K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	2,851	$336K
99214	Doctor's office visit, returning patient (more involved)	<1%	4,311	$336K
93017		<1%	10,862	$335K
73522		<1%	6,644	$329K
76882		<1%	7,173	$326K
77063	Screening digital breast tomosynthesis, bilateral	<1%	22,893	$326K
73110		<1%	16,350	$322K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,112	$318K
43276		<1%	118	$318K
52310		<1%	326	$318K
90834	Psychotherapy session, about 45 minutes	<1%	6,076	$315K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	59,625	$314K
82728		<1%	82,553	$314K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,782	$311K
10061		<1%	1,120	$310K
73130		<1%	18,532	$309K
97035		<1%	4,021	$309K
47000		<1%	306	$306K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	1,258	$305K
97165		<1%	3,976	$303K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	2,568	$300K
86870		<1%	1,808	$296K
72170		<1%	8,706	$294K
51784		<1%	3,092	$292K
43259		<1%	391	$292K
86003		<1%	9,837	$289K
95700		<1%	2,188	$285K
95708		<1%	905	$284K
93880		<1%	2,965	$272K
86803		<1%	44,161	$271K
30520		<1%	208	$267K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	2,908	$264K
87481		<1%	6,785	$264K
77080		<1%	2,977	$258K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	230,577	$257K
73562		<1%	7,577	$255K
96450		<1%	1,065	$254K
J9042	Injection, brentuximab vedotin, 1 mg	<1%	47	$253K
92582		<1%	4,619	$249K
93225		<1%	6,087	$246K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	24,855	$244K
93451		<1%	139	$243K
92557		<1%	4,239	$242K
92588		<1%	993	$241K
95076		<1%	533	$239K
J1750	Injection, iron dextran, 50 mg	<1%	1,298	$238K
70486		<1%	8,440	$237K
74174		<1%	1,728	$236K
90651		<1%	1,465	$233K
73700		<1%	3,101	$229K
C9062	Injection, daratumumab 10 mg and hyaluronidase-fihj	<1%	106	$229K
83013		<1%	4,705	$229K
96401		<1%	13,717	$229K
25605		<1%	182	$228K
73140		<1%	10,355	$224K
J2796	Injection, romiplostim, 10 micrograms	<1%	495	$222K
93923		<1%	3,256	$222K
J9145	Injection, daratumumab, 10 mg	<1%	336	$219K
92526		<1%	2,380	$217K
95715		<1%	699	$217K
82310		<1%	516,547	$215K
94010		<1%	15,254	$209K
87506		<1%	3,748	$208K
83970		<1%	19,453	$208K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,320	$206K
94621		<1%	1,545	$200K
72157		<1%	2,826	$198K
20552		<1%	1,073	$195K
58300		<1%	1,090	$195K
87632		<1%	8,578	$191K
86832		<1%	2,292	$189K
43762		<1%	1,049	$188K
72040		<1%	9,259	$187K
83550		<1%	73,618	$185K
72070		<1%	5,352	$185K
77338		<1%	1,298	$181K
J9228	Injection, ipilimumab, 1 mg	<1%	26	$181K
81382		<1%	597	$176K
92586		<1%	1,339	$175K
77290		<1%	996	$175K
71271		<1%	1,785	$171K
86833		<1%	2,294	$169K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	358	$166K
97163		<1%	2,868	$166K
74018		<1%	8,798	$164K
87086	Culture, bacterial; quantitative colony count, urine	<1%	113,452	$164K
72146		<1%	2,255	$162K
94375		<1%	10,884	$155K
77072		<1%	3,708	$155K
87536		<1%	14,782	$155K
76818		<1%	1,496	$154K
73590		<1%	11,173	$151K
92610		<1%	905	$149K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	60,988	$149K
75574		<1%	1,649	$149K
96402		<1%	10,027	$148K
20611		<1%	805	$148K
90686		<1%	15,940	$148K
70546		<1%	408	$147K
V5090	Dispensing fee, unspecified hearing aid	<1%	367	$146K
74220		<1%	1,541	$146K
87653		<1%	10,352	$145K
83540		<1%	78,117	$144K
51700		<1%	1,163	$141K
73080		<1%	8,968	$140K
51729		<1%	356	$139K
0012A		<1%	3,814	$138K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	20,630	$138K
72050		<1%	3,328	$137K
95806		<1%	1,357	$133K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	38,594	$133K
72082		<1%	4,744	$133K
90837	Psychotherapy session, about an hour	<1%	1,993	$133K
77280		<1%	1,814	$132K
92552		<1%	3,835	$131K
87340		<1%	42,775	$131K
36590		<1%	197	$131K
0011A		<1%	4,041	$130K
C9463	Injection, aprepitant, 1 mg	<1%	771	$129K
76813		<1%	2,606	$128K
95908		<1%	583	$128K
64447		<1%	1,741	$126K
97760		<1%	3,173	$126K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,642	$126K
78264		<1%	501	$125K
90677		<1%	941	$124K
84439		<1%	44,472	$123K
29848		<1%	85	$123K
51728		<1%	290	$123K
10005		<1%	302	$121K
84403		<1%	11,306	$120K
82746		<1%	22,894	$120K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	1,026	$120K
90732		<1%	2,096	$117K
90670		<1%	1,277	$114K
82465		<1%	87,633	$114K
73552		<1%	6,956	$113K
74170		<1%	1,233	$113K
51705		<1%	1,130	$112K
49591		<1%	40	$110K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,912	$109K
84702		<1%	43,425	$109K
95953		<1%	301	$106K
76000		<1%	1,644	$105K
76870		<1%	5,339	$103K
72110		<1%	3,154	$103K
93304		<1%	252	$101K
J2356	Injection, tezepelumab-ekko, 1 mg	<1%	42	$101K
73120		<1%	2,470	$100K
72195		<1%	545	$99K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	576	$99K
26055		<1%	175	$97K
Q3014	Telehealth originating site facility fee	<1%	15,934	$97K
70487		<1%	774	$95K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	1,214	$94K
73720		<1%	417	$94K
86706		<1%	24,275	$93K
82784		<1%	38,114	$93K
96112		<1%	493	$92K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	18,282	$92K
73718		<1%	480	$92K
36522		<1%	32	$91K
86923		<1%	8,388	$89K
83655		<1%	22,657	$89K
86235		<1%	5,515	$87K
87522	Neg quan hep c or qual rna	<1%	6,571	$86K
64415		<1%	2,002	$86K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	989	$86K
72131		<1%	1,788	$86K
29075		<1%	378	$84K
36591		<1%	6,590	$84K
92652		<1%	789	$83K
70480		<1%	1,011	$83K
77073		<1%	2,155	$83K
J9303	Injection, panitumumab, 10 mg	<1%	53	$82K
82570		<1%	58,408	$82K
73200		<1%	1,128	$82K
90675		<1%	305	$81K
74240		<1%	623	$80K
93926		<1%	1,733	$80K
64616		<1%	766	$80K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	193	$80K
72190		<1%	1,014	$80K
77470		<1%	407	$79K
36589		<1%	275	$79K
36592		<1%	7,608	$78K
85610		<1%	112,356	$78K
57522		<1%	39	$77K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	665	$77K
87631		<1%	4,018	$77K
77062		<1%	6,023	$76K
31624		<1%	276	$76K
55700		<1%	99	$75K
62270		<1%	152	$74K
73070		<1%	4,045	$73K
82374		<1%	531,694	$72K
73090		<1%	8,478	$72K
83735		<1%	158,103	$72K
73000		<1%	2,621	$72K
J9171	Injection, docetaxel, 1 mg	<1%	2,811	$72K
86360		<1%	14,637	$72K
99215	Doctor's office visit, returning patient (complex)	<1%	627	$71K
82670		<1%	6,047	$71K
11100		<1%	336	$69K
85027		<1%	65,685	$69K
86140		<1%	62,754	$69K
83001		<1%	8,913	$69K
87497		<1%	10,988	$68K
94660		<1%	3,871	$68K
C8924	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study	<1%	717	$68K
86038		<1%	16,439	$67K
86147		<1%	5,121	$67K
83880		<1%	35,281	$67K
49505		<1%	25	$66K
72081		<1%	3,582	$65K
86704		<1%	18,268	$65K
95912		<1%	158	$65K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	299	$65K
84146		<1%	7,302	$64K
11102		<1%	547	$64K
81479	Unlisted molecular pathology procedure	<1%	248	$63K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	6,132	$63K
76885		<1%	877	$62K
86905		<1%	732	$62K
86618		<1%	9,135	$62K
59820		<1%	25	$62K
20605		<1%	360	$62K
93296		<1%	3,920	$61K
J0517	Injection, benralizumab, 1 mg	<1%	27	$61K
84425		<1%	6,019	$61K
83002		<1%	8,125	$60K
84270		<1%	6,219	$59K
29515		<1%	477	$59K
82105		<1%	12,445	$59K
81378		<1%	252	$58K
86922		<1%	2,337	$58K
86160		<1%	10,017	$58K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	13	$57K
74160		<1%	684	$57K
82043		<1%	26,998	$56K
86146		<1%	4,269	$56K
73060		<1%	4,791	$56K
30140		<1%	201	$55K
80061	Lipid panel	<1%	30,455	$55K
64635		<1%	39	$55K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	7,183	$55K
58301		<1%	329	$54K
37243		<1%	13	$54K
87186		<1%	32,466	$54K
90746		<1%	1,484	$53K
81001		<1%	132,408	$53K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,692	$52K
57454		<1%	220	$52K
97542		<1%	2,203	$51K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	231	$51K
83721		<1%	12,038	$51K
51725		<1%	283	$51K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	448	$50K
80197		<1%	21,084	$50K
92651		<1%	406	$48K
99195		<1%	1,027	$47K
85055		<1%	24,153	$47K
87077		<1%	28,081	$47K
86008		<1%	1,506	$47K
87799		<1%	7,379	$47K
J0739	Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)	<1%	12	$46K
84153		<1%	11,390	$46K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	78	$46K
84478		<1%	83,544	$46K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	31,960	$46K
74181		<1%	575	$46K
83516		<1%	8,804	$45K
84480		<1%	7,501	$44K
84402		<1%	3,971	$44K
90378		<1%	18	$43K
66982		<1%	47	$43K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	16,629	$43K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	57,921	$43K
96910		<1%	2,437	$43K
81508		<1%	1,442	$43K
86708		<1%	9,946	$43K
64400		<1%	190	$43K
51702		<1%	2,350	$42K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	697	$42K
84445		<1%	2,221	$42K
G0378	Hospital observation service, per hour	<1%	99,325	$41K
64999		<1%	2,002	$41K
86334		<1%	11,858	$41K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,501	$41K
93925		<1%	485	$41K
92585		<1%	225	$40K
96523		<1%	2,776	$39K
95813		<1%	425	$39K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	14,986	$39K
71101		<1%	3,472	$38K
J1930	Injection, lanreotide, 1 mg	<1%	18	$38K
97763		<1%	2,180	$38K
74241		<1%	206	$38K
81206		<1%	2,367	$38K
95117		<1%	997	$37K
82951		<1%	3,373	$37K
86787		<1%	13,486	$36K
29581		<1%	511	$35K
82950		<1%	9,055	$35K
86762		<1%	14,799	$35K
80053	Comprehensive metabolic panel	<1%	191,155	$35K
85730		<1%	49,803	$35K
V5011	Fitting/orientation/checking of hearing aid	<1%	1,258	$34K
83921		<1%	7,632	$34K
82785		<1%	8,427	$34K
85652		<1%	50,395	$34K
76080		<1%	138	$34K
77373		<1%	53	$33K
86769		<1%	1,028	$33K
J1729	Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg	<1%	175	$33K
77061		<1%	2,784	$33K
54640		<1%	14	$33K
51798		<1%	19,586	$32K
74019		<1%	3,183	$32K
64454		<1%	115	$32K
V5264	Ear mold/insert, not disposable, any type	<1%	1,164	$32K
86830		<1%	624	$32K
87529		<1%	3,114	$32K
92511		<1%	219	$32K
83520		<1%	5,496	$31K
83525		<1%	5,497	$31K
82627		<1%	3,664	$31K
97755		<1%	2,277	$31K
88342		<1%	8,545	$31K
86682		<1%	2,331	$30K
87517		<1%	2,574	$30K
83521		<1%	8,912	$30K
81003		<1%	79,566	$29K
95712		<1%	184	$29K
73660		<1%	2,853	$29K
86765		<1%	3,948	$29K
J2315	Injection, naltrexone, depot form, 1 mg	<1%	46	$28K
86735		<1%	3,494	$28K
86665		<1%	5,182	$28K
82652		<1%	1,485	$28K
86225		<1%	7,763	$28K
82533		<1%	5,900	$28K
87070		<1%	20,645	$27K
86696		<1%	2,986	$27K
86831		<1%	624	$27K
84165		<1%	18,095	$27K
0031A		<1%	1,839	$27K
74455		<1%	192	$27K
83014		<1%	4,672	$27K
Q0222	Injection, bebtelovimab, 175 mg	<1%	17	$26K
83690		<1%	100,453	$25K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,858	$25K
95819		<1%	119	$25K
43264		<1%	80	$25K
83021		<1%	13,941	$25K
76604		<1%	1,677	$25K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	376	$24K
94726		<1%	1,316	$24K
86376		<1%	5,661	$24K
75716		<1%	41	$23K
82088		<1%	1,431	$23K
74221		<1%	172	$23K
84156		<1%	34,120	$23K
84207		<1%	1,909	$23K
J9155	Injection, degarelix, 1 mg	<1%	217	$23K
94728		<1%	2,553	$23K
84630		<1%	3,915	$23K
91122		<1%	132	$22K
42821		<1%	18	$22K
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	<1%	26	$22K
67311		<1%	12	$22K
86359		<1%	14,643	$22K
86800		<1%	4,447	$22K
82248		<1%	154,825	$22K
93786		<1%	295	$22K
85245		<1%	4,150	$22K
93990		<1%	900	$21K
95816		<1%	89	$21K
58100		<1%	145	$21K
86705		<1%	5,232	$21K
82024		<1%	1,516	$21K
64445		<1%	536	$21K
82378		<1%	14,809	$21K
86850		<1%	76,535	$21K
88304		<1%	7,557	$21K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	51	$20K
83883		<1%	8,133	$20K
97129		<1%	255	$20K
83498		<1%	2,180	$20K
92950		<1%	130	$20K
70360		<1%	1,696	$20K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,460	$20K
86364		<1%	5,142	$20K
76775		<1%	2,633	$20K
80048	Basic metabolic panel (calcium, ionized)	<1%	96,773	$20K
J1611	Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg	<1%	425	$19K
54163		<1%	14	$19K
73521		<1%	1,018	$19K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	98	$19K
11721		<1%	1,937	$19K
90662		<1%	3,158	$19K
85244		<1%	4,159	$19K
86695		<1%	2,986	$19K
80177		<1%	5,668	$19K
85240		<1%	4,813	$18K
83993		<1%	1,614	$18K
64612		<1%	120	$18K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	556	$18K
41010		<1%	15	$18K
11981		<1%	357	$18K
43760		<1%	70	$18K
52287		<1%	27	$18K
86709		<1%	4,603	$17K
87088		<1%	10,712	$17K
52332		<1%	12	$17K
98967		<1%	971	$17K
86431		<1%	8,551	$17K
73100		<1%	1,682	$17K
86200		<1%	4,551	$17K
94664		<1%	6,058	$17K
87338		<1%	1,863	$17K
86255		<1%	2,445	$16K
38505		<1%	34	$16K
91120		<1%	88	$16K
31628		<1%	51	$16K
93242		<1%	1,145	$16K
84305		<1%	3,231	$16K
83519		<1%	2,558	$16K
95713		<1%	56	$16K
86039		<1%	4,720	$16K
45381		<1%	42	$16K
84432		<1%	2,755	$16K
62321		<1%	25	$15K
73650		<1%	704	$15K
80164		<1%	5,218	$15K
88142		<1%	1,428	$15K
31526		<1%	14	$15K
78582		<1%	97	$15K
C9447	Injection, phenylephrine and ketorolac, 4 ml vial	<1%	139	$15K
0240U		<1%	122	$15K
82397		<1%	3,498	$15K
91010		<1%	45	$15K
85598		<1%	3,695	$14K
72220		<1%	920	$14K
51720		<1%	94	$14K
90792	Psychiatric diagnostic evaluation with medical services	<1%	113	$14K
83090		<1%	3,390	$14K
85046		<1%	24,846	$14K
87205		<1%	19,822	$14K
71100		<1%	896	$14K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	1,007	$14K
G0424	Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day	<1%	660	$14K
84244		<1%	1,595	$14K
70481		<1%	104	$14K
95250		<1%	154	$13K
87640		<1%	1,701	$13K
81025		<1%	105,382	$13K
92960		<1%	54	$13K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,961	$13K
85007		<1%	34,823	$13K
86304		<1%	5,811	$13K
86258		<1%	2,165	$13K
80175		<1%	2,727	$13K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	40	$13K
84460		<1%	385,201	$13K
87081		<1%	6,899	$13K
72080		<1%	584	$12K
86664		<1%	4,805	$12K
97032		<1%	146	$12K
73600		<1%	739	$12K
82157		<1%	1,402	$12K
87209		<1%	1,884	$12K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	39	$12K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	63	$12K
85379		<1%	22,271	$12K
29065		<1%	51	$12K
0071A		<1%	336	$12K
G0239	Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)	<1%	807	$12K
10022		<1%	30	$11K
10120		<1%	42	$11K
88307		<1%	4,844	$11K
94618		<1%	3,237	$11K
92567		<1%	25,071	$11K
0072A		<1%	296	$11K
88300		<1%	7,205	$11K
46607		<1%	27	$11K
17250		<1%	1,230	$11K
86592		<1%	3,324	$11K
86341		<1%	945	$11K
86301		<1%	5,286	$11K
95913		<1%	27	$10K
19081		<1%	18	$10K
72128		<1%	200	$10K
11056		<1%	314	$10K
64490		<1%	13	$10K
72072		<1%	773	$10K
93299		<1%	491	$10K
83010		<1%	9,418	$10K
82565		<1%	552,767	$10K
28285		<1%	14	$10K
72120		<1%	392	$9K
87449		<1%	4,230	$9K
86335		<1%	3,226	$9K
97014		<1%	149	$9K
87324		<1%	2,923	$9K
97597		<1%	123	$9K
73620		<1%	429	$9K
82139		<1%	1,619	$9K
P9011	Blood, split unit	<1%	143	$9K
92551		<1%	1,452	$9K
87177		<1%	1,861	$9K
86300		<1%	6,726	$9K
91040		<1%	38	$9K
84166		<1%	3,386	$8K
76826		<1%	35	$8K
82390		<1%	2,777	$8K
14060		<1%	15	$8K
98968		<1%	506	$8K
84134		<1%	1,888	$8K
82150		<1%	4,839	$8K
85613		<1%	3,759	$8K
43238		<1%	13	$8K
80183		<1%	2,006	$8K
82787		<1%	1,680	$8K
87075		<1%	9,520	$8K
86812		<1%	1,123	$8K
49452		<1%	12	$8K
24640		<1%	43	$8K
91322		<1%	320	$8K
82952		<1%	2,835	$8K
82164		<1%	1,813	$8K
17110		<1%	407	$8K
80299		<1%	1,605	$7K
74175		<1%	646	$7K
86617		<1%	718	$7K
J2597	Injection, desmopressin acetate, per 1 mcg	<1%	258	$7K
57455		<1%	32	$7K
31267		<1%	14	$7K
82140		<1%	4,503	$7K
86880		<1%	2,898	$7K
82550		<1%	22,480	$7K
82103		<1%	1,802	$7K
86021		<1%	2,113	$7K
0054A		<1%	348	$7K
75580		<1%	17	$7K
73723		<1%	31	$7K
82542		<1%	1,023	$7K
84484		<1%	135,407	$7K
12001		<1%	5,281	$7K
84481		<1%	1,450	$7K
45331		<1%	14	$6K
84144		<1%	499	$6K
80156		<1%	1,441	$6K
11982		<1%	30	$6K
83615		<1%	56,163	$6K
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	<1%	53	$6K
82525		<1%	1,839	$6K
91035		<1%	12	$6K
12011		<1%	4,380	$6K
82085		<1%	1,915	$6K
90480		<1%	349	$6K
86381		<1%	684	$6K
70250		<1%	471	$6K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	590	$6K
72192		<1%	113	$6K
31500		<1%	52	$5K
92522		<1%	28	$5K
86316		<1%	1,724	$5K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	64	$5K
59841		<1%	144	$5K
92612		<1%	64	$5K
11900		<1%	309	$5K
81596		<1%	141	$5K
81269		<1%	46	$5K
87300		<1%	923	$5K
97167		<1%	95	$5K
J7342	Instillation, ciprofloxacin otic suspension, 6 mg	<1%	247	$5K
82239		<1%	639	$5K
97022		<1%	64	$5K
0124A		<1%	244	$5K
85306		<1%	1,447	$5K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	1,766	$5K
87808		<1%	4,316	$5K
69210		<1%	2,777	$5K
83835		<1%	827	$5K
82232		<1%	2,464	$5K
72193		<1%	46	$5K
84202		<1%	515	$5K
86357		<1%	2,711	$5K
86355		<1%	2,703	$5K
91200		<1%	43	$5K
51741		<1%	2,776	$5K
86256		<1%	299	$5K
0004A		<1%	221	$5K
87015		<1%	6,066	$4K
81372		<1%	32	$4K
84450		<1%	370,944	$4K
19301		<1%	17	$4K
31615		<1%	15	$4K
84154		<1%	733	$4K
74740		<1%	17	$4K
97164		<1%	427	$4K
86015		<1%	1,301	$4K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	170	$4K
82274		<1%	391	$4K
83020		<1%	591	$4K
86645		<1%	2,688	$4K
87493		<1%	603	$4K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	282	$4K
86644		<1%	3,806	$4K
82435		<1%	509,162	$4K
94625		<1%	448	$4K
86580		<1%	1,107	$4K
80178		<1%	2,876	$4K
82340		<1%	2,026	$4K
87116		<1%	2,727	$4K
87102		<1%	3,831	$4K
86593		<1%	1,077	$4K
82166		<1%	285	$4K
76820		<1%	6,047	$4K
84410		<1%	111	$4K
84145		<1%	11,599	$4K
93271		<1%	54	$4K
80235		<1%	635	$4K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	3,081	$4K
82379		<1%	782	$3K
84681		<1%	501	$3K
89051		<1%	6,034	$3K
85018		<1%	25,638	$3K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	964	$3K
88360		<1%	2,898	$3K
82803		<1%	53,276	$3K
85303		<1%	1,153	$3K
76821		<1%	855	$3K
20550		<1%	12	$3K
82668		<1%	1,619	$3K
86036		<1%	1,088	$3K
91065		<1%	27	$3K
83605		<1%	57,427	$3K
81207		<1%	380	$3K
84436		<1%	1,285	$3K
87252		<1%	425	$3K
94680		<1%	668	$3K
85300		<1%	1,402	$3K
84446		<1%	727	$3K
87329		<1%	510	$3K
87902		<1%	44	$3K
94642		<1%	1,825	$3K
87040		<1%	16,377	$3K
85576		<1%	743	$3K
86666		<1%	435	$3K
92555		<1%	2,638	$3K
85384		<1%	5,718	$3K
87101		<1%	674	$3K
87184		<1%	2,463	$3K
96377		<1%	4,723	$3K
88112		<1%	3,721	$3K
80076		<1%	4,295	$3K
73503		<1%	84	$3K
87206		<1%	3,643	$3K
92570		<1%	66	$3K
93979		<1%	127	$3K
83695		<1%	459	$3K
86317		<1%	1,294	$3K
93888		<1%	34	$3K
80184		<1%	7,926	$3K
85014		<1%	42,911	$3K
12002		<1%	2,783	$3K
92609		<1%	31	$2K
91037		<1%	12	$2K
77332		<1%	42	$2K
84590		<1%	719	$2K
84550		<1%	24,394	$2K
85520		<1%	827	$2K
81050		<1%	1,676	$2K
80185		<1%	655	$2K
87625		<1%	190	$2K
57452		<1%	16	$2K
86308		<1%	2,041	$2K
82330		<1%	42,110	$2K
82172		<1%	354	$2K
93280		<1%	2,563	$2K
87484		<1%	320	$2K
87468		<1%	320	$2K
93312		<1%	16	$2K
86753		<1%	320	$2K
84100		<1%	66,964	$2K
76828		<1%	156	$2K
81270		<1%	780	$2K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	34	$2K
84600		<1%	3,317	$2K
81002		<1%	74,957	$2K
80201		<1%	484	$2K
84300		<1%	2,775	$2K
92250		<1%	275	$2K
90740		<1%	17	$2K
83935		<1%	1,590	$2K
86777		<1%	1,039	$2K
81267		<1%	304	$2K
20600		<1%	14	$2K
83789		<1%	373	$1K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,805	$1K
J3490	Unclassified drugs	<1%	1,382,905	$1K
82104		<1%	1,033	$1K
82962		<1%	32,046	$1K
29125		<1%	1,726	$1K
92556		<1%	4,579	$1K
11104		<1%	16	$1K
70549		<1%	24	$1K
82017		<1%	318	$1K
81240		<1%	1,301	$1K
84132		<1%	523,175	$1K
11057		<1%	12	$1K
82523		<1%	288	$1K
82610		<1%	575	$1K
82010		<1%	4,081	$1K
82977		<1%	15,128	$1K
84520		<1%	540,987	$1K
83930		<1%	1,288	$1K
86901		<1%	79,350	$1K
89060		<1%	985	$1K
72052		<1%	26	$1K
0052A		<1%	45	$1K
95249		<1%	18	$1K
90636		<1%	48	$1K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	4,058	$1K
82945		<1%	1,750	$1K
11055		<1%	46	$1K
84157		<1%	2,024	$1K
80158		<1%	546	$1K
86340		<1%	257	$1K
93283		<1%	1,346	$1K
84295		<1%	533,153	$997.02
88185		<1%	9,880	$970.28
0064A		<1%	53	$960.00
84133		<1%	1,616	$957.63
87220		<1%	466	$956.45
80051		<1%	2,358	$954.90
87563		<1%	87	$933.28
86162		<1%	296	$931.20
80203		<1%	197	$911.52
93284		<1%	994	$861.71
84030		<1%	208	$854.69
92060		<1%	2,288	$815.29
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	15	$806.00
82436		<1%	1,189	$798.59
90715		<1%	11,770	$795.54
86337		<1%	142	$793.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	103	$788.93
85049		<1%	872	$774.18
85651		<1%	3,217	$747.80
89230		<1%	14	$744.51
12013		<1%	545	$730.57
82270		<1%	308	$705.97
94250		<1%	768	$704.67
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	136,051	$678.30
80180		<1%	231	$672.36
69200		<1%	707	$671.44
93922		<1%	13	$658.60
0003A		<1%	31	$640.00
80074		<1%	296	$639.65
87305		<1%	1,970	$629.75
81241		<1%	966	$625.18
92597		<1%	14	$611.10
0111A		<1%	39	$600.00
0053A		<1%	33	$600.00
89050		<1%	1,941	$593.83
72114		<1%	59	$592.30
80195		<1%	439	$589.95
64643		<1%	1,154	$553.49
84075		<1%	376,761	$550.25
76942		<1%	4,846	$546.08
76380		<1%	12	$537.68
87207		<1%	729	$528.68
76776		<1%	17	$527.14
0051A		<1%	31	$520.00
88173		<1%	1,679	$511.20
72200		<1%	30	$510.54
82180		<1%	223	$509.76
85250		<1%	238	$509.04
88313		<1%	4,222	$507.14
82731		<1%	21	$492.16
46600		<1%	148	$489.64
95012		<1%	11,697	$484.04
76872		<1%	62	$482.33
83529		<1%	104	$482.04
85270		<1%	228	$478.80
96376		<1%	35,475	$453.51
86382		<1%	16	$452.20
94727		<1%	12,945	$449.27
76999		<1%	13	$443.70
93282		<1%	286	$418.92
85247		<1%	113	$416.29
87147		<1%	393	$414.59
83037		<1%	6,721	$401.32
80050	General health panel	<1%	787	$396.21
82075		<1%	8,069	$388.96
83918		<1%	83	$361.56
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,518	$351.38
84238		<1%	116	$349.20
71111		<1%	15	$348.63
74328		<1%	557	$320.78
87641		<1%	1,531	$317.08
93226		<1%	5,746	$309.29
99152		<1%	12,021	$302.64
82595		<1%	106	$290.46
88182		<1%	707	$282.34
84182		<1%	46	$274.88
J9181	Injection, etoposide, 10 mg	<1%	2,668	$269.04
J9263	Injection, oxaliplatin, 0.5 mg	<1%	8,198	$266.00
C1726	Catheter, balloon dilatation, non-vascular	<1%	715	$263.84
76981		<1%	439	$245.22
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	7,264	$235.68
87328		<1%	45	$229.00
82955		<1%	99	$212.75
90656		<1%	218	$211.75
81340		<1%	12	$199.51
81342		<1%	27	$192.43
99153	Mod sedat endo service >5yrs	<1%	11,029	$191.98
76937		<1%	3,555	$191.96
81401		<1%	184	$191.80
93246		<1%	16	$191.13
51701		<1%	20	$189.24
17000		<1%	25	$182.77
93320		<1%	13,120	$174.00
84252		<1%	25	$166.80
82653		<1%	29	$160.68
82530		<1%	19	$159.60
94799		<1%	425	$157.23
81219		<1%	15	$155.38
84311		<1%	594	$153.64
81208		<1%	118	$153.60
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	2,779	$150.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,353	$147.04
84155		<1%	357,405	$144.64
82365		<1%	193	$135.41
87350		<1%	40	$132.12
86747		<1%	216	$129.24
82375		<1%	267	$117.70
J9045	Injection, carboplatin, 50 mg	<1%	11,638	$115.96
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	900	$113.80
80069		<1%	140	$113.17
86707		<1%	38	$110.50
99407		<1%	413	$109.63
76376		<1%	11,309	$100.00
84540		<1%	247	$99.88
86774		<1%	89	$98.91
81257		<1%	128	$98.32
73565		<1%	13	$98.24
92583		<1%	605	$97.82
80047		<1%	964	$96.16
87899		<1%	68	$91.60
97130		<1%	201	$91.53
86684		<1%	29	$90.78
87176		<1%	282	$84.30
86778		<1%	121	$82.56
95886		<1%	4,618	$75.39
J2785	Injection, regadenoson, 0.1 mg	<1%	7,331	$72.00
87593		<1%	46	$67.02
85670		<1%	67	$66.12
J1790	Injection, droperidol, up to 5 mg	<1%	8,508	$65.86
93325		<1%	22,809	$65.60
80220		<1%	15	$65.40
80165		<1%	61	$63.74
11720		<1%	27	$62.69
84591		<1%	15	$61.68
82438		<1%	14	$54.36
88341		<1%	4,664	$50.74
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	6,673	$50.73
89055		<1%	42	$48.84
86060		<1%	12	$48.79
J7120	Ringers lactate infusion, up to 1000 cc	<1%	109,218	$46.06
94760		<1%	28,875	$43.91
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	13	$42.49
86687		<1%	156	$40.10
87181		<1%	94	$38.28
86790		<1%	53	$36.93
J2270	Injection, morphine sulfate, up to 10 mg	<1%	41,398	$36.88
84466		<1%	35	$36.57
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	112,512	$36.49
C1769	Guide wire	<1%	7,215	$35.65
84597		<1%	16	$35.56
82042		<1%	35	$34.58
82657		<1%	13	$34.48
88302		<1%	522	$34.40
87430		<1%	303	$34.35
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	58,672	$32.02
C2617	Stent, non-coronary, temporary, without delivery system	<1%	1,903	$29.29
88240		<1%	205	$28.95
93356		<1%	3,678	$28.23
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	24,036	$26.65
87185		<1%	306	$26.10
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	1,201	$23.90
S5553	Insulin, long acting; 5 units	<1%	3,494	$23.02
J1836	Injection, metronidazole, 10 mg	<1%	788	$22.63
85305		<1%	15	$22.16
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	122,989	$21.85
85347		<1%	2,262	$20.35
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	22,535	$19.52
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	1,016	$18.12
J2598	Injection, vasopressin, 1 unit	<1%	200	$16.41
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	10,446	$15.10
J8597	Antiemetic drug, oral, not otherwise specified	<1%	9,639	$13.39
93291		<1%	32	$13.27
80162		<1%	27	$12.68
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,771	$12.60
J0690	Injection, cefazolin sodium, 500 mg	<1%	43,605	$12.20
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	3,840	$12.07
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,692	$11.97
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	83,885	$11.81
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	98,263	$11.25
86635		<1%	17	$10.96
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	60,818	$10.73
J3475	Injection, magnesium sulfate, per 500 mg	<1%	17,413	$8.62
G0008	Administration of influenza virus vaccine	<1%	2,473	$8.00
J1939	Injection, bumetanide, 0.5 mg	<1%	50	$7.68
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,515	$6.91
J2704	Injection, propofol, 10 mg	<1%	5,908	$6.26
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	36,690	$6.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	17,239	$4.84
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	172	$4.08
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	27,952	$3.97
J1815	Injection, insulin, per 5 units	<1%	20,902	$3.90
G0475	Hiv antigen/antibody, combination assay, screening	<1%	902	$3.87
J9260	Injection, methotrexate sodium, 50 mg	<1%	1,198	$2.50
C9113	Injection, pantoprazole sodium, per vial	<1%	3,846	$2.40
J1650	Injection, enoxaparin sodium, 10 mg	<1%	36,525	$2.30
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	334	$2.28
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	4,079	$2.12
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	253	$2.08
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	40,507	$2.07
S0028	Injection, famotidine, 20 mg	<1%	119	$2.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	215	$1.74
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	492	$1.50
J8540	Dexamethasone, oral, 0.25 mg	<1%	21,710	$1.39
J1644	Injection, heparin sodium, per 1000 units	<1%	31,714	$1.35
96368		<1%	6,918	$1.28
J1953	Injection, levetiracetam, 10 mg	<1%	1,076	$1.25
J9370	Vincristine sulfate, 1 mg	<1%	3,112	$1.25
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	131	$1.00
J3480	Injection, potassium chloride, per 2 meq	<1%	4,874	$0.93
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	132	$0.77
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	96	$0.57
J1630	Injection, haloperidol, up to 5 mg	<1%	5,459	$0.48
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	3,072	$0.44
J3030	Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	176	$0.22
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	98	$0.20
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	98	$0.20
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	96	$0.18
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	15	$0.10
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	15	$0.10
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	686	$0.06
J1170	Injection, hydromorphone, up to 4 mg	<1%	20,159	$0.03
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	7,794	$0.00
95885		0%	3,192	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	4,507	$0.00
64494		0%	1,288	$0.00
51797		0%	1,335	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	31,016	$0.00
A9567	Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries	0%	97	$0.00
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	0%	13	$0.00
J3535	Drug administered through a metered dose inhaler	0%	10,843	$0.00
36416		0%	17,754	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	2,089	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	3,716	$0.00
C1781	Mesh (implantable)	0%	1,459	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	11,103	$0.00
J2700	Injection, oxacillin sodium, up to 250 mg	0%	34	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	2,458	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	4,197	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	3,584	$0.00
99070		0%	796	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	3,927	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	3,001	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	1,551	$0.00
77001		0%	2,173	$0.00
64484		0%	224	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	1,280	$0.00
G0009	Administration of pneumococcal vaccine	0%	389	$0.00
99156		0%	147	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	9,461	$0.00
0482T		0%	711	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	5,028	$0.00
J2060	Injection, lorazepam, 2 mg	0%	12,711	$0.00
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	0%	135	$0.00
J7999	Compounded drug, not otherwise classified	0%	11,255	$0.00
0399T		0%	214	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	6,858	$0.00
Q0175	Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	409	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	231	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	3,853	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	11,743	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	12,941	$0.00
V2632	Posterior chamber intraocular lens	0%	2,876	$0.00
93788		0%	273	$0.00
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	0%	163	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	195	$0.00
88311		0%	3,103	$0.00
87071		0%	424	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	1,516	$0.00
91305		0%	600	$0.00
C1830	Powered bone marrow biopsy needle	0%	82	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	1,468	$0.00
76377		0%	2,837	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	916	$0.00
J0697	Injection, sterile cefuroxime sodium, per 750 mg	0%	979	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	2,630	$0.00
J0280	Injection, aminophyllin, up to 250 mg	0%	982	$0.00
C1819	Surgical tissue localization and excision device (implantable)	0%	500	$0.00
C1759	Catheter, intracardiac echocardiography	0%	17	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	33,250	$0.00
64488		0%	58	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	231	$0.00
J9250	Methotrexate sodium, 5 mg	0%	648	$0.00
88331		0%	646	$0.00
A4648	Tissue marker, implantable, any type, each	0%	1,593	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	489	$0.00
84260		0%	14	$0.00
81000		0%	123	$0.00
81511		0%	121	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	437	$0.00
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	0%	29	$0.00
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	0%	31	$0.00
99406		0%	15	$0.00
91307		0%	447	$0.00
C1778	Lead, neurostimulator (implantable)	0%	31	$0.00
91303		0%	1,835	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	752	$0.00
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	0%	43	$0.00
51600		0%	323	$0.00
82810		0%	16	$0.00
88348		0%	25	$0.00
C1753	Catheter, intravascular ultrasound	0%	83	$0.00
93290		0%	13	$0.00
77417		0%	51	$0.00
C1886	Catheter, extravascular tissue ablation, any modality (insertable)	0%	87	$0.00
11045		0%	19	$0.00
91301		0%	7,843	$0.00
88150		0%	13	$0.00
49424		0%	74	$0.00
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	0%	168	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	16	$0.00
43273		0%	26	$0.00
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	41	$0.00
61782		0%	45	$0.00
36247		0%	17	$0.00
30901		0%	85	$0.00
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	0%	84	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	17	$0.00
81255		0%	31	$0.00
J0713	Injection, ceftazidime, per 500 mg	0%	37	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	45	$0.00
82360		0%	30	$0.00
J7507	Tacrolimus, immediate release, oral, 1 mg	0%	32	$0.00
11730		0%	13	$0.00
J2404	Injection, nicardipine, 0.1 mg	0%	24	$0.00
C2625	Stent, non-coronary, temporary, with delivery system	0%	516	$0.00
78434		0%	1,890	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	6,130	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	9,105	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	6,515	$0.00
93321		0%	4,223	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	3,453	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	6,858	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	10,613	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	4,792	$0.00
00170	Anesthesia for intraoral procedures, including biopsy	0%	30	$0.00
92978		0%	53	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	1,078	$0.00
J9206	Injection, irinotecan, 20 mg	0%	5,638	$0.00
J9999	Not otherwise classified, antineoplastic drugs	0%	2,746	$0.00
58340		0%	272	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	1,927	$0.00
77002		0%	3,992	$0.00
95874		0%	676	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	3,755	$0.00
94729		0%	15,457	$0.00
J1071	Injection, testosterone cypionate, 1 mg	0%	778	$0.00
99177		0%	573	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	1,571	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	2,083	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	5,895	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	17,356	$0.00
88312		0%	1,954	$0.00
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	0%	521	$0.00
C1874	Stent, coated/covered, with delivery system	0%	879	$0.00
J1240	Injection, dimenhydrinate, up to 50 mg	0%	2,927	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	13,062	$0.00
75565		0%	2,185	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	33,848	$0.00
76827		0%	5,047	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	9,532	$0.00
C1788	Port, indwelling (implantable)	0%	1,390	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	9,119	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	3,336	$0.00
77387		0%	4,703	$0.00
Q9954	Oral magnetic resonance contrast agent, per 100 ml	0%	8,079	$0.00
C1782	Morcellator	0%	102	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	1,361	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	1,861	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	214	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	6,763	$0.00
C1776	Joint device (implantable)	0%	1,177	$0.00
99151		0%	1,107	$0.00
J9000	Injection, doxorubicin hydrochloride, 10 mg	0%	3,903	$0.00
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	0%	655	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	2,000	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	548	$0.00
81243		0%	43	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	1,814	$0.00
77012		0%	2,017	$0.00
86904		0%	175	$0.00
88344		0%	65	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	129	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	1,046	$0.00
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	0%	6,003	$0.00
99173		0%	1,038	$0.00
92504		0%	465	$0.00
C1729	Catheter, drainage	0%	1,389	$0.00
90461		0%	5,657	$0.00
Q9956	Injection, octafluoropropane microspheres, per ml	0%	350	$0.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	0%	393	$0.00
C1758	Catheter, ureteral	0%	1,289	$0.00
A9520	Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries	0%	45	$0.00
J7510	Prednisolone oral, per 5 mg	0%	221	$0.00
91300		0%	30,594	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	938	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	39,961	$0.00
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	0%	388	$0.00
81403		0%	73	$0.00
75571		0%	12	$0.00
16020		0%	43	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	15	$0.00
92015	Determination of refractive state	0%	390	$0.00
77003		0%	15	$0.00
81406		0%	80	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	1,664	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	432	$0.00
76001		0%	136	$0.00
62322		0%	46	$0.00
81404		0%	79	$0.00
91312		0%	219	$0.00
88381		0%	139	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	567	$0.00
99442		0%	213	$0.00
80143		0%	139	$0.00
95887		0%	38	$0.00
64495		0%	50	$0.00
64636		0%	13	$0.00
90648		0%	28	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	16	$0.00
92134		0%	14	$0.00
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	0%	43	$0.00
90653		0%	172	$0.00
95018		0%	33	$0.00
J7517	Mycophenolate mofetil, oral, 250 mg	0%	105	$0.00
C1762	Connective tissue, human (includes fascia lata)	0%	16	$0.00
91311		0%	44	$0.00
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	0%	17	$0.00
99157		0%	53	$0.00
75774		0%	12	$0.00
81422		0%	40	$0.00
69209		0%	14	$0.00
93613		0%	17	$0.00
C1876	Stent, non-coated/non-covered, with delivery system	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWRINN, JACQUELINE (DIRECTOR)

Same official

Other billing entities under WRINN, JACQUELINE

Full network →

Provider	Location	Paid
Bridgeport Hospital	Bridgeport, CT	$287.34M
Lawrence and Memorial Hospital, INC.	New London, CT	$136.19M
Greenwich Hospital	Greenwich, CT	$46.42M
Bridgeport Hospital	Milford, CT	$15.60M
LMW Healthcare INC.	Westerly, RI	$13.10M
Lawrence and Memorial Hospital, INC.	New London, CT	$1.55M
Yale New Haven Hospital	New Haven, CT	$629K
LMW Healthcare INC.	Westerly, RI	$492K
Bridgeport Hospital	Bridgeport, CT	$398K
Lawrence and Memorial Hospital, INC.	New London, CT	$365K
Shoreline Endoscopy Center, LLC	Guilford, CT	$19K
Yale New Haven Hospital	New Haven, CT	$860.83

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.